Oncology Archives - Infectious Disease Advisor

Study authors measured seroprevalence of measles and mumps among cancer patients and compared seroprevalence based on demographic, disease, and treatment subgroups.

COVID19

Risk of SARS-CoV-2 Contamination in Radiation Oncology Clinics

By

Rita Aghjayan

October 9, 2020

While several studies have investigated SARS-CoV-2 contamination in health care settings, patterns in oncology clinics with fewer COVID-19 cases is unclear.

Risks of moving clinical trials online include missing key information about the patient experience — and higher dropout rates could also impair the overall quality of trials.

COVID19

How the Coronavirus Pandemic May Affect Cancer Clinical Trials

By

Agata Boxe

October 8, 2020

Risks of moving clinical trials online include missing key information about the patient experience — and higher dropout rates could also impair the overall quality of trials.

The approval is based on evidence that the vaccine can prevent anogenital infections, with an ongoing trial looking at throat infection prevention in men likely to be critical for continued approval.

Prevention

European Myeloma Network Provides Vaccine Recommendations for MM

By

Leah Lawrence

September 11, 2020

Patients with myeloma should receive 2 doses of the trivalent or quadrivalent vaccine influenza vaccine and vaccinations should continue annually.

Infections often precede a formal diagnosis of CLL. Researchers found that antimicrobial use began to rise 6 years prior to CLL diagnosis.

Prevention

CLL Diagnosis Preceded by Decades of Increased Infection Susceptibility

By

Katarina Zimmer, MSci, MS

September 3, 2020

Infections often precede a formal diagnosis of CLL. Researchers found that antimicrobial use began to rise 6 years prior to CLL diagnosis.

Weakened strain of Clostridium novyi-NT bacteria thrives in low oxygen environment.

Mycoses

Increased Risk of Mycobacterial Infection With Immune Checkpoint Inhibitors

By

Christina Bennett, MS

September 2, 2020

Using FAERS, study researchers identified reported cases of tuberculosis and atypical mycobacterial infection in patients who received ICIs.

Computer illustration of Burkitt lymphoma.

HIV/AIDS

Understanding the Oncogenic Role of HIV in Burkitt Lymphoma

By

Tori Rodriguez, MA, LPC, AHC

August 31, 2020

While the rate of certain HIV-linked non-Hodgkin lymphomas has declined since the introduction of ART, the incidence of Burkitt lymphoma has remained steady.

Two studies characterize hematological recovery after CAR-T cell therapy.

Hepatitis

ASCO Issues Provisional Opinion Update on Hepatitis B Screening

By

Leah Lawrence

August 24, 2020

ASCO recommends that patients with newly diagnosed cancer slated to receive systemic anticancer meds be tested for HBV by 3 tests prior to starting therapy.